You are now leaving Amgen Australia’s website. Amgen Australia takes no responsibility for the information contained on the Amgen international server or site which you will be accessing. The information you are about to access may not comply with the Australian regulatory environment.
For Australian specific enquiries, please click here.
You are now leaving Amgen Australia’s website. Amgen Australia takes no responsibility for, and exercises no control over the organisation, views, or information contained on the server or site which you will be accessing. The information contained might not comply with the Australian regulatory environment.
Amgen’s mission is to serve patients, and through continued improvement and specialised technology, we reliably and expertly turn molecules into medicines that reach millions of patients around the world. Our industry-leading manufacturing capabilities combined with our process development expertise, expands what is possible in the fight for patients.
Our unique Amgen methodology marries unconventional thinking with data-driven analysis to deliver therapies of increasing sophistication. This includes a growing number of new drug delivery devices designed to enhance the experience of patients who use our medicines.
Biomanufacturing requires advanced science, specialized technology, and a talented and highly committed staff. At Amgen, we continually invest in our manufacturing to strengthen our industry-leading capabilities and extend our global reach.
Amgen's first manufacturing platform began in 1988 and produced just 200 grams of our first biologic medicine.
Nearly 40 years later, Amgen manufactures more than a dozen medicines for difficult-to-treat diseases, leveraging its manufacturing network around the world.
In Singapore, we built our first state of art biomanufacturing facility, best in class of its kind, spanning 120, 000 square meters.
This is significantly smaller than a typical conventional plant, Rhode Island followed suit and replicated this new way of operating and North Carolina building is underway.
today, Amgen strives to develop more sophisticated technology and deliver medicines more cost-effectively and as quickly as possible.
On this journey, we continuously ensure we've strengthened our supply chain resilience by investing in new processes because delivering high-quality medicines helps our mission to serve patients.
Amgen has established a long history of successfully inventing industry-leading technologies and investing in innovation to develop and manufacture biologic medicines for patients with serious illnesses.
At Amgen, we all rally to our common purpose of serving every patient, every time. This commitment requires us to innovate – to rethink how we manufacture, package and deliver products that reach patients when needed, and perform as needed. At every stage of the manufacturing process, we develop and implement innovative technologies to maximise efficiency, quality, safety, and sustainability in service of our mission.
Continuous Improvement is at the heart of everything we do. Every dollar and hour saved, can be used to advance our pipeline, improve - even further - our industry leading manufacturing, and enable us to supply our patients today, and more tomorrow.